Literature DB >> 15194447

Effect of the 5HT1A receptor partial agonist buspirone on colorectal distension-induced pseudoaffective and behavioral responses in the female Wistar rat.

Digavalli V Sivarao1, Kimberly Newberry, Nicholas J Lodge.   

Abstract

In the present study, we have evaluated the visceral analgesic property of buspirone, a 5HT(1A) receptor partial agonist, on colorectal distension-induced mean arterial pressure and behavioral changes in anesthetized and awake Wistar rats, respectively. The selection of the rat strain was based on the observation that anesthetized Wistar rats exhibited a more prominent mean arterial pressure change in response to colorectal distention when compared to other strains (Sprague-Dawley, Wistar-Kyoto and Spontaneously Hypertensive). Buspirone dose-dependently (0.1-1 mg/kg, i.v.) antagonized mean arterial pressure change over a range of distensions (10-90 mmHg). In parallel studies conducted in awake animals, buspirone (1-5 mg/kg, s.c.) attenuated the abdominal withdrawal response, a nociceptive behavior, in response to colorectal distension. This effect was antagonized by co-administration of the 5-HT(1A) receptor antagonist N-[2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl]-N-2- pyridinylcyclohexanecarboxamide (WAY-100635) (5 mg/kg, s.c.). We conclude that buspirone exhibits significant visceral analgesic property in two models of abdominal nociception.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194447     DOI: 10.1016/j.ejphar.2004.04.034

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Antinociceptive effect of the agonist of 5-HT1A receptors buspirone in the model of abdominal pain in dogs.

Authors:  O A Lyubashina; I I Busygina; S S Panteleev; A D Nozdrachev
Journal:  Dokl Biol Sci       Date:  2017-05-16

2.  Pronociceptive effect of 5-HT(1A) receptor agonist on visceral pain involves spinal N-methyl-D-aspartate (NMDA) receptor.

Authors:  A Mickle; P Kannampalli; M Bruckert; A Miranda; B Banerjee; J N Sengupta
Journal:  Neuroscience       Date:  2012-05-22       Impact factor: 3.590

Review 3.  Stress and visceral pain: from animal models to clinical therapies.

Authors:  Muriel Larauche; Agata Mulak; Yvette Taché
Journal:  Exp Neurol       Date:  2011-05-06       Impact factor: 5.330

4.  Effects of pregabalin on visceral pain responses and colonic compliance in rats.

Authors:  A Ravnefjord; M Brusberg; H Larsson; E Lindström; V Martínez
Journal:  Br J Pharmacol       Date:  2008-06-23       Impact factor: 8.739

Review 5.  Serotonin pharmacology in the gastrointestinal tract: a review.

Authors:  D T Beattie; J A M Smith
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-09       Impact factor: 3.000

6.  Brain-Gut Interactions in IBS.

Authors:  Jakub Fichna; Martin A Storr
Journal:  Front Pharmacol       Date:  2012-07-05       Impact factor: 5.810

7.  Inflammatory pain and corticosterone response in infant rats: effect of 5-HT1A agonist buspirone prior to gestational stress.

Authors:  Irina P Butkevich; Viktor A Mikhailenko; Tat'yana R Bagaeva; Elena A Vershinina; Anna Maria Aloisi; Vladimir A Otellin
Journal:  Mediators Inflamm       Date:  2013-03-31       Impact factor: 4.711

8.  Effect of DA-9701 on colorectal distension-induced visceral hypersensitivity in a rat model.

Authors:  Eun Ran Kim; Byung-Hoon Min; Tae Ho Lee; Miwon Son; Poong-Lyul Rhee
Journal:  Gut Liver       Date:  2014-01-14       Impact factor: 4.519

9.  Buspirone in the management of refractory irritable bowel syndrome: A case report.

Authors:  Mustafa Abdul Karim; Nadeen Al-Baz; Peter M Haddad; Shuja M Reagu; Majid Alabdulla
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.